Literature DB >> 19822122

First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009.

M Osterblad1, J Kirveskari, S Koskela, P Tissari, K Vuorenoja, A J Hakanen, M Vaara, J Jalava.   

Abstract

The first two Klebsiella pneumoniae carbapenemase-producing (KPC) type 2 strains carrying ST258 were detected in Finland in June and early August 2009. They were found colonising two patients transferred from the Mediterranean; one patient referred from a hospital in Greece where isolates were first found in 2007 and another from Italy where the first isolates have been described only very recently.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19822122

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  15 in total

1.  KPC-2-producing Klebsiella pneumoniae isolated from a Czech patient previously hospitalized in Greece and in vivo selection of colistin resistance.

Authors:  Jaroslav Hrabák; Jana Niemczyková; Eva Chudáčková; Marta Fridrichová; Vendula Studentová; Dana Cervená; Pavla Urbášková; Helena Zemličková
Journal:  Folia Microbiol (Praha)       Date:  2011-08-05       Impact factor: 2.099

2.  Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.

Authors:  Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Mark E Pulse; William J Weiss; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

3.  Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.

Authors:  Azita Leavitt; Yehuda Carmeli; Inna Chmelnitsky; Moran G Goren; Itzhak Ofek; Shiri Navon-Venezia
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

4.  Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae Carbapenemase 3 in an intensive care unit in Italy.

Authors:  Caterina Mammina; Daniela Maria Palma; Celestino Bonura; Maria Rosa Anna Plano; Rachele Monastero; Concetta Sodano; Cinzia Calà; Romano Tetamo
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

5.  KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.

Authors:  Ji-Young Rhee; Young Kyoung Park; Joo Yeon Shin; Ji Young Choi; Mi Young Lee; Kyong Ran Peck; Jae-Hoon Song; Kwan Soo Ko
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

6.  Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (bla KPC) variants.

Authors:  Liang Chen; José R Mediavilla; Andrea Endimiani; Marnie E Rosenthal; Yanan Zhao; Robert A Bonomo; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2010-12-01       Impact factor: 5.948

Review 7.  Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Ryan S Arnold; Kerri A Thom; Saarika Sharma; Michael Phillips; J Kristie Johnson; Daniel J Morgan
Journal:  South Med J       Date:  2011-01       Impact factor: 0.954

8.  Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary.

Authors:  A Tóth; I Damjanova; E Puskás; L Jánvári; M Farkas; A Dobák; K Böröcz; J Pászti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-18       Impact factor: 3.267

9.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

10.  Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.

Authors:  Christopher Lucasti; Liviu Vasile; Dorel Sandesc; Donatas Venskutonis; Patrick McLeroth; Mallika Lala; Matthew L Rizk; Michelle L Brown; Maria C Losada; Alison Pedley; Nicholas A Kartsonis; Amanda Paschke
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.